Heterocyclic derivatives

US7893073B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Heike Gielen-Haertwig · Monheim, DE
• Barbara Albrecht · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Volkhart Min-Jian Li · Velbert, DE
• Josef Pernerstorfer · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Leila Telan · Wuppertal, DE

Key dates

• Filing date: Feb 15, 2005
• Grant date: Feb 22, 2011
• Expiry date: Aug 12, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel 3,4-dihydropyrimidin-2(1H)-one derivatives having the formulaprocesses for their preparation, and their use in compositions, and in the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.